Wave Neuro, founded in 2019 by Fred Walke, is transforming mental healthcare with non-invasive, AI-driven neurotechnology. Inspired by his daughter's recovery from a brain injury using the company's technology, Walke committed to making these innovative treatments widely accessible.
Wave Neuro's technology, rooted in decades of research, personalizes brain treatments like TMS, showing three times the effectiveness of traditional methods. With over 15,000 patients treated globally, the company is leading the way in addressing conditions like PTSD and autism.
AI plays a vital role in analyzing brain data, allowing for proactive mental health care. As Wave Neuro expands and refines its technology, Walke remains dedicated to revolutionizing mental health treatment and improving lives worldwide.
